HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models.
Saved in:
| Title: | HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models. |
|---|---|
| Authors: | Nguyen TTT; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA., Zhang Y; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA., Shang E; Department of Biological Sciences, Bronx Community College, City University of New York, Bronx, New York, USA., Shu C; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA., Torrini C; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA., Zhao J; Department of Biomedical Informatics, Columbia University, New York, New York, USA., Bianchetti E; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA., Mela A; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA., Humala N; Department of Neurological Surgery, Columbia University Medical Center, New York, New York, USA., Mahajan A; Department of Neurological Surgery, Columbia University Medical Center, New York, New York, USA., Harmanci AO; Center for Precision Health, School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, Texas, USA., Lei Z; Core for Research Informatics, University of Illinois at Chicago, Chicago, Illinois, USA., Maienschein-Cline M; Core for Research Informatics, University of Illinois at Chicago, Chicago, Illinois, USA., Quinzii CM; Department of Neurology, Columbia University Medical Center, New York, New York, USA., Westhoff MA; Department of Pediatrics and Adolescent Medicine and., Karpel-Massler G; Department of Neurosurgery, Ulm University Medical Center, Ulm, Germany., Bruce JN; Department of Neurological Surgery, Columbia University Medical Center, New York, New York, USA., Canoll P; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA., Siegelin MD; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2020 Jul 01; Vol. 130 (7), pp. 3699-3716. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
